National Donor Deferral Registry (NDDR) Helps Ensure That Deferred Donors Cannot Donate Their Plasma Again
The National Donor Deferral Registry (NDDR) is a database of permanently deferred plasma donors in North America. It is one of many voluntary, self-regulating initiatives taken by the source plasma collection industry and is an important component of the industry-driven safety measures taken to help ensure the safety of the final therapies.
All donors who test "reactive" for the viral agents for HIV, HBV and HCV are added to the NDDR and are permanently prohibited from donating source plasma at participating licensed and industry-certified centers in the U.S. and Canada.
The NDDR first was made available to all blood and source plasma facilities in December 1993. Haemonetics, a valued partner of PPTA, is responsible for the administration and customer support services of the NDDR.
All inquires should be directed to the NDDR Customer Support Desk at 1-877-534-3578.
PPTA Recognizes First Plasma Collection Centers Certified in Hungary +
ANNAPOLIS, MD—The Plasma Protein Therapeutics Association (PPTA) has awarded Plazmaferezis Állomás Kft (PFÁ), a member operating within the Kedrion group of companies, with International Quality Plasma Program (IQPP) certification for its plasma collection centers in Hungary; two in Budapest and one in Debrecen. The three centers are the first in the country to become IQPP certified.Read More
PPTA's Updated Response to Ontario's Proposal to Ban Compensated Plasma Donation +
The Plasma Protein Therapeutics Association (PPTA) remains deeply concerned about the proposal to ban compensated plasma donation in the Province of Ontario, Canada. The proposed legislation, Ontario Bill 178, unfairly targets compensated plasma donation on alleged bases of safety and Canada’s goal of self-sufficiency in regards to the supply of plasma-derived medicinal products.Read More
PPTA's Response to Ontario's Proposal to Ban Compensated Plasma Donation +
Members of the Plasma Protein Therapeutics Association (PPTA) are deeply concerned regarding the proposed legislation in the province of Ontario. It appears to have a goal of eliminating the possibility of compensating devoted donors for their time and inconvenience associated with a process called plasmapheresis, used to collect source plasma, the essential ingredient of life-saving plasma protein therapies.Read More
PPTA Standards Programs